Fatty fish intake decreases lipids related to inflammation and insulin signaling - A lipidomics approach

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Lankinen, Maria ^a,b   Schwab, Ursula ^b,c   Erkkilä, Arja ^b   Seppänen Laakso, Tuulikki ^a   Hannila, Marja Leena ^b   Mussalo, Hanna ^c   Lehto, Seppo ^c   Uusitupa, Matti ^b   Gylling, Helena ^b,c   Orešič, Matej ^a  

^a VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE DERIVATIVE; CHOLESTEROL ESTER; DIACYLGLYCEROL; INSULIN; LIPID; LONG CHAIN TRIACYLGLYCEROL; LYSOPHOSPHATIDYLCHOLINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID;

ANIMAL PRODUCT; ARTICLE; ATHEROSCLEROSIS; BEEF; CHICKEN MEAT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FAT INTAKE; FISH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPIDOMICS; PILOT STUDY; PORK; RANDOMIZED CONTROLLED TRIAL; VASCULAR DISEASE; ANIMAL; BLOOD; BODY MASS; LIPID METABOLISM; METABOLISM;

ANIMALS; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; DIETARY FATS; FATTY ACIDS, OMEGA-3; FISHES; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS;

EID: 65449152613     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005258     Document Type: Article

References (34)

1. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, et al. (2006) N-3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84: 5-17.
2. He K, Song Y, Daviglus ML, Liu K, Van Horn L, et al. (2004) Accumulated evidence on fish consumption and coronary heart disease mortality. Circulation 109: 2705-2711.
3. Breslow JL (2006) N-3 Fatty acids and cardiovascular disease. Am J Clin Nutr 83(suppl): 1477S-1482S.
4. Philibert A, Vanier C, Abdelouahab N, Chan HM, Mergler D (2006) Fish intake and serum fatty acid profiles from freshwater fish. Am J Clin Nutr 84: 1299-1307.
5. Mozaffarian D, Lemaitre RN, Kuller LH, Burke GL, Tracy RP, et al. (2003) Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 107: 1372-1377.
6. Nettleton JA, Katz R (2005) N-3 Long-Chain Polyunsaturated Fatty Acids in Type 2 Diabetes: A Review. J Am Diet Assoc 105: 428-440.
7. Feskens EJ, Bowles CH, Kromhout D (1991) Inverse association between fish intake and risk of glucose intolerance in normoglycemis elderly men and women. Diabetes Care 14: 935-941.
8. Browning LM, Krebs JD, Moore CS, Mishra GD, ÒConnel MA, et al. (2007) The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 9: 70-80.
9. Ramel A, Martinéz A, Kiely M, Morais G (2008) Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults. Diabetologia 51: 1261-1268.
10. Mori TA, Bao DQ, Burke V, Puddey IB, Watts GF, et al. (1999) Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 70: 817-825.
11. Giacco R, Cuomo V, Vessby B, Uusitupa M, Hermansen K, et al. (2007) Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids? Nutr Metab Cardiovasc Dis 17: 572-580.
12. Taouis M, Dagou C, Ster C, Durand G, Pinault M, et al. (2002) N-3 Polyunsaturated fatty acids prevent the defect of insulin receptor signaling in muscle. Am J Physiol Endocrinol Metab 282: E664-E671.
13. Lombardo YB, Hein G, Chicco A (2007) Metabolic syndrome: effects of n-3 PUFAs on a model of dyslipidemia, insulin resistance and adiposity. Lipids 42: 427-437.
14. Madsen T, Skou HA, Hansen VE, Fog L, Christensen JH, et al. (2001) C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol 88: 1139-1142.
15. Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Sobajic S, et al. (2007) Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients. Ren Fail 29: 321-329.
16. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, et al. (1993) The relation between insulin sensitivity and the fatty-acid composition of skeletal muscle phospholipids. N Engl J Med 328: 238-244.
17. Blank ML, Smith ZL, Cress EA, Snyder F (1994) Molecular species of ethanolamine plasmalogens and transacylase activity in rat tissues are altered by fish oil diets. Biochim Biophys Acta 1214: 295-302.
18. Wymann MP, Schneiter R (2008) Lipid signalling in disease. Nat Rev Mol Cell Biol 9: 162-176.
19. Turpin SM, Lancaster GI, Darby I, Febbraio MA, Watt MJ (2006) Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance. Am J Physiol Endocrinol Metab 291: E1341-E1350.
20. Holland WL, Knotts TA, Chavez JA, Wang L-P, Hoehn KL, et al. (2007) Lipid mediators of insulin resistance. Nutrition Reviews 65: S39-S46.
21. Timmers S, Schrauwen P, de Vogel J (2008) Muscular diacylglycerol metabolism and insulin resistance. Physiology & Behavior, In press.
22. Jolly CA, Jiang Y-H, Chapkin RS, McMurray DN (1997) Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and ceramide. J Nutr 127: 37-43.
23. Erkkila AT, Schwab US, de Mello VDF, Lappalainen T, Mussalo H, et al. (2008) Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications. Eur J Nutr 47: 319-328.
24. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, et al. (2006) Diet and Lifestyle Recommendations Revision 2006. A Scientific Statement from the American Heart Association Nutrition Committee. Circulation 114: 82-96.
25. Schwab U, Seppänen-Laakso T, Yetukuri L, Ågren J, Kolehmainen M, et al. (2008) Triacylglycerol Fatty Acid Composition in Diet-Induces Weight Loss in Subjects with Abnormal Glucose Metabolism - the GENOBIN Study. PLoS ONE 7: e2630.
26. Katajamaa M, Miettinen J, Orešič M (2006) Mzmine, toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics 22: 634-636.
27. R Development Core Team (2007) R, A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org.
28. Storey JD (2002) A direct approach to false discovery rates. J R Stat Soc B 64: 479-498.
29. Aiyar N, Disa J, Ao Z, Ju H, Nerurkar S, et al. (2007) Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells. Mol Cell Biochem 295: 113-120.
30. Huang YH, Schäfer-Elinder L, Wu R, Claesson H-E, Frostegård J (1999) Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clin Exp immunol 116: 326-331.
31. Summers SA (2006) Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45: 42-72.
32. Engelman B (2004) Plasmalogens: targets for oxidants and major lipophilic antioxidants. Biochem Soc Trans 32: 147-150.
33. Gaposchkin DP, Zoeller RA (1999) Plasmalogen status influences docosahexaenoic acid levels in a macrophage cell line: insights using ether lipid-deficient variants. J Lipid Res 40: 495-503.
34. Laaksonen R, Katajamaa M, Päivä H, Sysi-Aho M, Saarinen L, et al. (2006) A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle. PLoS ONE 1: e97.